CIK 0001645469 · Non-accelerated filer<br>Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320463781
- Phone
- 8473880349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Chief Executive Officer acquired 62,815 shares (other)
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,558 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,889 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at $69.95 ($104,925)
- 4 Open-market sale Director sold 5,121 shares at an average $67.15 ($343,889)
- 4 Other disposition 10% owner disposed of 43,499 shares (other)
- 4 Other acquisition Director acquired 7,710 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,896 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,646 shares (to pay taxes)
Page 2 of 13 · 247 filings